Anthera Pharmaceuticals Inc - ANTH - Financial Statement Analysis
All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.
In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.
Financial statement analysis updated: May 26, 2013
Anthera Pharmaceuticals Inc - SIC # 8731
| Ticker | Exchange | SIC # | Website | Latest Ticker |
|---|---|---|---|---|
| ANTH | Nasdaq | 8731 | http://www.anthera.com/ |
0.5999  -0.007
|
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: |
||||
Latest Headlines for Anthera Pharmaceuticals Inc
ANTHERA PHARMACEUTICALS INC Financials - May 21st, 2013 11:04 am
Anthera Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript - May 20th, 2013 5:20 pm
ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or - May 17th, 2013 6:37 am
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results - May 13th, 2013 3:22 pm
ANTHERA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report - May 13th, 2013 7:01 am
View All Current Headlines >> |
||||
